Moreover, both PAR2 [58] and TGF-β/ALK5 [59] promote angiogenesis through expression and release of VEGF and subsequent VEGFR transactivation and are thus essential for tumor survival under hypoxic conditions. The gene discussed is F2RL1; the disease is neoplasm.